The dream for a new cancer treatment is big, but Soon-Shiong’s public companies have not fared well in the markets beyond their initial IPOs.
The dream for a new cancer treatment is big, but Soon-Shiong’s public companies have not fared well in the markets beyond their initial IPOs.